REDUCTION OF SYMPTOMS AND BREATH H2 PRODUCTION IN A SUBGROUP OF PATIENTS WITH IRRITABLE BOWEL SYNDROME CHARACTERIZED BY DISTINCT GUT MICROBIOTA ACTIVITY: EFFECT OF A FERMENTED MILK PRODUCT CONTAINING BIFIDOBACTERIUM LACTIS CNCM I-2494

(1) Danone Research Deprt. of Life Science, Dept. of Life Sciences, Palaiseau, France

(2) INRA MetaGenoPolis, MICALIS, Jouy-en-Josas, France

(3) University of Gothenburg, Dept. of Internal Medicine and Clinical Nutrition, Gothenburg, Sweden

(4) Sahlgrenska University Hospital, Dept of Internal Medicine and Clinical Nutrition, Gothenburg, Sweden



This item was part of UEG Week 2016

This item can be cited as: United European Gastroenterology Journal; 2016: 2 (Supplement 1)

You may be interested in:

Advances in clinical research
English, Abstract, European Society of Neurogastroenterology and Motility (ESNM), American Neurogastroenterology and Motility Society (ANMS), 2012

Categorisation:

  • Format
    • Abstract
  • Year
    • 2016